Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing
Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116